PRIP Call 2 – Pharma MedTech R&D Scheme (Concept Notes)
Under PRIP (Promotion of Research and Innovation in Pharma MedTech Sector) by Department of Pharmaceuticals
Check your eligibility
Go Premium and we'll tell you whether your startup qualifies for this grant.
Quick Answer
Financial assistance to MSMEs and startups for R&D and commercialization of drugs and medical devices under the Promotion of Research and Innovation in Pharma-MedTech Sector (PRIP) scheme.
- Funding amount
- Up to ₹100 Cr
- Funding type
- Grant
- Provider
- Department of Pharmaceuticals
- Application deadline
- Rolling
- Location
- Open to startups registered in India
About this grant
The Promotion of Research and Innovation in Pharma–MedTech Sector (PRIP) scheme, launched by the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India, is a flagship initiative designed to transform India's Pharma–MedTech industry. Its core aim is to shift the sector from a cost-based manufacturing hub to an innovation-driven global leader in R&D. With a substantial outlay of ₹5,000 crore, the scheme strategically allocates funds to foster rapid discovery, development, and commercialization of critical drugs and advanced medical devices.
PRIP seeks to significantly bolster indigenous innovation and strengthen industry–academia collaboration across the pharmaceutical and medical technology landscapes. This includes support for both early-stage projects focusing on foundational research (TRL 1-3) and later-stage innovations (TRL 4-6) pushing towards market readiness. The scheme specifically targets high-impact areas such as new chemical and biological entities, complex generics, biosimilars, and novel medical devices incorporating cutting-edge technologies like AI/ML and robotics. By providing crucial financial assistance and fostering a collaborative ecosystem, PRIP aims to accelerate the development of groundbreaking solutions that address India's public health priorities and establish the nation as a global leader in health-tech innovation.
Eligibility
See if you're eligible
Full eligibility criteria — entity type, stage, sector, founder profile and registration requirements — plus your fit for this program. Go Premium to view.
Grant providers
The Department of Pharmaceuticals is a department under the Ministry of Chemicals & Fertilizers, Government of India. Created on July 1, 2008, the department was established to provide greater focus for the growth of India's high-potential pharmaceutical industry, one of the…
Learn moreBenefits & Funding
- Amount
- Up to ₹100 Cr
- Fund type
- Grant
- Repayment
- Non-repayable
What You Get
The PRIP scheme offers substantial financial assistance, with grants ranging up to ₹100 crore per project, depending on the stage and category. This funding is disbursed in four milestone-linked instalments, ensuring alignment with project progress. For Early Stage projects, assistance is up to ₹5 crore, with full funding up to ₹1 crore and 50% co-funding required for amounts above that. NCE/NBE Discovery Track projects can receive up to ₹50 crore, requiring a minimum of 25% co-funding from institutional investors. Later Stage projects are eligible for up to ₹100 crore with assistance up to 35-50% of the project cost. Beyond capital, the program actively promotes industry-academia collaboration, fostering a robust innovation ecosystem. Successful projects also engage in a benefit-share mechanism on commercialization, often through Compulsory Convertible Preference Shares (CCPS), reflecting a partnership approach to commercial success.
- Disbursement
- Milestone Based
Timelines & Process
Applications
Rolling basis
Selection Process
The selection process for PRIP Call 2 involves multiple stages. For Early-Stage and NCE/NBE Discovery Tracks, submitted Concept Notes first undergo a rigorous screening to ensure eligibility and alignment with scheme objectives. This is followed by a technical evaluation to assess the project's potential, novelty, implementation plan, and team credentials. Only projects that are shortlisted from this Concept Note stage, along with direct applications for the Later-Stage Track, proceed to submit a detailed application form. These detailed applications are then evaluated against comprehensive criteria including impact on India's public health priorities, technical rigor, soundness of funding and expenditure plans, credentials of the team and academic partners, market potential, and scalability.
Application Process
- 1
Submit Concept Note
Applicants for Early-Stage and NCE/NBE Discovery Tracks submit a Concept Note.
You - 2
- 3
- 4
- 5
- 6
- 7
How to apply
Four steps from draft to disbursement — one action each.
- 1
Draft your application
Answer the form inside the grant tracker — AI drafts each response using your past answers, so you're not starting from a blank page.
- 2
See the questions before you start
Download every question this programme's application form asks, so you can prepare your answers offline before opening the portal.
- 3
Line up your documents
Keep every document from the checklist ready in one folder. Missing docs are the #1 reason applications get bounced.
- 4
Submit on the official portal
Use the official application link and verify all details before final submission.
- 5
Follow up
Reach out 5–7 days after submitting to confirm receipt and ask about the review timeline.
Program templates & documents
Files the program publishes for applicants — download these and apply in the prescribed format.
Frequently Asked Questions
What is the PRIP scheme's main objective?
The PRIP scheme aims to transform India's Pharma–MedTech sector from a cost-based industry into an innovation-driven global powerhouse for R&D, enabling rapid discovery, development, and commercialization of drugs and medical devices.
Who is eligible to apply for PRIP Call 2?
Eligible applicants include MSMEs and DPIIT-recognized startups that are registered in India as companies (excluding OPCs and Section 8 companies), LLPs, or registered partnership firms. Ecosystem enablers may also submit on behalf of promising projects or entities within their network.
What kind of projects are supported by PRIP?
PRIP supports projects in new medicines (including new chemical and biological entities, gene/cell therapy, phytopharmaceuticals, and traditional Indian medicines), complex generics & biosimilars, and novel medical devices (including AI/ML, SaMD/SiMD, genetic diagnostics, surgical robotics, telemedicine devices, and novel IVDs).
What are the funding amounts available?
Financial assistance is provided up to ₹5 crore for Early Stage Projects, up to ₹50 crore for NCE/NBE Discovery Track, and up to ₹100 crore for Later Stage Projects.
Is co-funding required for projects under PRIP?
Yes, co-funding is required. For Early Stage projects requesting over ₹1 crore, 50% co-funding is needed. For NCE/NBE Discovery Track, a minimum of 25% co-funding from a bona fide institutional investor is mandatory.
How is funding disbursed and what are the terms of engagement?
Funding is disbursed in four milestone-linked instalments into a dedicated project bank account. Upon commercialization, there is a benefit-share agreement on net sales, or alternatively, share allotment through Compulsory Convertible Preference Shares (CCPS) as preferred.
What are the Technology Readiness Level (TRL) requirements?
Early Stage projects must have completed TRL 1, 2, or 3, aiming to reach up to TRL 5. Later Stage projects should have completed TRL 4, 5, or 6, aiming for higher TRLs. Projects already at TRL 7 or above are not eligible.
Sources
Data on this page is compiled from official program and provider references.
